Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Formulation and Evaluation of Nifedipine Transdermal Drug Delivery Systems
Formulation and Evaluation of Nifedipine Transdermal Drug Delivery Systems
Fuente:
Zenodo
Saved in:
Bibliographic Details
Main Author:
Kolluru Lavanya, Dr. B. Nagamani*, B. Renuka, Dr. P. Umadevi
Format:
Recurso digital
Published:
Zenodo
2025
Subjects:
Nifedipine, Transdermal Patches, HPMC K100, Eudragit L100, Iontophoresis, DMSO, Permeation Enhancers, Controlled Drug Release, Antihypertensive Therapy
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://doi.org/10.5281/zenodo.15753454
Similar Items
Magnitud, velocidad y eficacia antihipertensiva de la Nifedipina de liberación programada en microgránulos en el tratamiento de pacientes con hipertensión arterial esencial
by: M. González
Published: (2004)
Advanced Formulation Strategies for Aceclofenac Transdermal Patches: Polymers, Permeation Enhancers, and Controlled Release Approaches
by: Harshit Kumar Giri*, Pradeep Kumar
Published: (2026)
A Comprehensive Review of Transdermal Patches for Wound Healing
by: Priyanshu Dewangan1, Aditya Kumar2, Rupesh Pal3, Gautam Kumar Yadav4, Chandraprabha Dewangan*5, Harish Sharma6, Gyanesh Kumar Sahu7
Published: (2025)
Formulation And Evaluation of Transdermal Patches from Thespesia Populnea for Anti-Inflammatory Activity
by: Ramanamma. L. 1*, Navya Jyothi.C. H. 2, Shivangi Dimple. B. 3, Sravya Sri P. R. 4, Bavana. K.5, Sravani. N. 6
Published: (2026)
A Research on: Formulation and Evaluation of Sustained Release matrix Tablets
by: Anuradha R. Narwade, et al.
Published: (2024)